Early-stage biotech company. Using editing RNA technologies to develop edit-to-cure therapeutics for previously undruggable target conditions. #EDIRNA

ID: 1616640970879111168

linkhttp://www.EDIRNA.us calendar_today21-01-2023 03:37:05